Trial intelligence / Profile preview

Remimazolam vs propofol vs sevoflurane for recovery after thoracoscopic lung resection

ChiCTR2600131359Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Soochow University
Start
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial comparing Sevoflurane group, Remimazolam group and Propofol group (3 arms). Primary endpoint: 24-hour postoperative recovery quality. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

remimazolampropofolsevoflurane

Beyond the preview

Go deeper on ChiCTR2600131359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600131359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call